As shown in Table 3, in the whole cohort of COVID-19 patients, there was a significant association between higher serum IL-6 levels and risk of having severe COVID-19 (unadjusted model: OR 1.06 [95% CI 1.03–1.09], p<0.001). This evidence concerns the gene IL6 and COVID-19.